Latest News From Pharmachem
-
Shire to purchase Dyax for $5.9bn
03 November, 2015
Dublin-based Shire has agreed to buy Dyax Corp for about $5.9 billion to gain access to the drug developer’s late-stage experimental treatment for a dangerous inflammatory disease that can block breathing
-
AstraZeneca to buy US firm ZS Pharma for €2.5bn
09 November, 2015
Drug giant AstraZeneca has agreed to buy US firm ZS Pharma in a $2.7bn (€2.5bn) cash deal. It will give UK-based AstraZeneca access to a drug that could potentially treat life-threatening condition, hyperkalaemia. The drug, ZS-9, is currently under regulatory review by the US Food and Drug Administration.
-
PharmaChem Skillnet Foot in the Door Event 2015
19 November, 2015
Our Annual Foot in the Door event takes place on Monday 23rd November in the Clayton Silversprings Hotel, Tivoli, Cork between 6.00pm and 9pm.
-
Great turnout for PharmaChem Skillnet Foot in the Door 2015
26 November, 2015
The PharmaChem Skillnet hosted its Annual Foot in the Door Event for Jobseekers on Monday 23rd November at the Clayton Silversprings Hotel, Cork. There was great support from Industry with several of the companies in attendance currently recruiting.